Proteopedia - User contributions [en]

Nithin 6wxd

2025-11-30T18:29:08Z

Racha Nithin: Removing all content from page

R.Nithin 6WXD sandbox

2025-11-30T18:28:29Z

Racha Nithin: New page: SARS-CoV-2 Non-structural Protein 9 (Nsp9) – Structure and Peptide-Binding Insights This page provides a structural and functional overview of the SARS-CoV-2 Nsp9 protein, based on the ...

SARS-CoV-2 Non-structural Protein 9 (Nsp9) – Structure and Peptide-Binding Insights
This page provides a structural and functional overview of the SARS-CoV-2 Nsp9 protein,
based on the 2020 iScience study that solved its crystal structure in both apo and
unexpected peptide-bound forms.
In this study , the researchers produced SARS-CoV-2 Nsp9 in the lab and sloved its X-ray crystal structure

<StructureSection load='6wxd' size='340' side='right'caption='[[6wxd]], [[Resolution|resolution]] 2.00Å' scene=''>

== Introduction ==

The <scene name='10/1096916/Overview/1'>SARS-CoV-2 Non-structural protein 9 (Nsp9)</scene> is a small but essential RNA-binding protein encoded by
SARS-CoV-2. It contributes to viral replication by stabilizing viral RNA and assisting the
replication–transcription machinery. Nsp9 is highly conserved across coronaviruses, indicating
that its structure is crucial for efficient genome replication.

crystal structure in two states:

* **Apo Nsp9** – Nsp9 without any ligand
* **Peptide-bound Nsp9** – unexpectedly containing a short peptide (**LEVL**) derived from a
rhinovirus 3C protease cleavage tag used during purification

The peptide was found bound close to the **dimer interface**, causing subtle but significant
changes in the relative orientation of the two Nsp9 monomers. Since Nsp9 functions as a
homodimer during RNA binding, even small shifts in this interface may influence replication
efficiency and protein–RNA interactions.

The structure confirmed that SARS-CoV-2 Nsp9 maintains a highly conserved **oblong β-barrel
fold**, similar to Nsp9 structures from SARS-CoV and other coronaviruses. The discovery of an
unexpected peptide-binding site suggests that Nsp9 may interact with regulatory elements or
protein partners during viral replication.

== Structure highlights ==

The SARS-CoV-2 Nsp9 monomer adopts a compact **7-stranded β-barrel fold**, a hallmark feature
of the Nsp9 family. Two monomers form a **homodimer**, which is necessary for RNA-binding
function.

=== β-Barrel Core ===

<scene name='10/1096916/Beta_barrel/4'>beta barrel structure</scene>
The Nsp9 monomer contains **seven antiparallel β-strands** arranged into a barrel-like fold.
This β-barrel provides rigidity and forms the structural foundation needed for RNA interaction.
The fold is nearly identical to SARS-CoV Nsp9, highlighting strong evolutionary conservation.
The central feature of SARS-CoV-2 Nsp9 is its compact seven-stranded β-barrel, which gives the
protein a stable and highly conserved structural backbone. The strands are arranged in an oblong,
slightly twisted barrel that creates a rigid core ideal for interacting with viral RNA. This
β-barrel fold is almost identical across coronavirus Nsp9 proteins, showing how crucial it is
for viral replication. By providing a firm scaffold and maintaining the protein’s overall shape,
the β-barrel helps Nsp9 position itself correctly during RNA binding and supports the dimer
formation needed for its function.
=== Dimer Interface ===

<scene name='10/1096916/Dimer_interface/1'>dimer interface</scene>
Nsp9 functions as a **homodimer**. The dimer interface is primarily stabilized by:
* β5–β6 region interactions
* Hydrophobic packing
* A conserved **GxGxG motif** situated near the dimerization surface

The alignment of the two monomers creates a positively charged groove thought to accommodate
viral RNA.

=== Peptide-Binding Site (LEVL peptide) ===

In the peptide-bound structure of Nsp9 (6WXD), a short LEVL peptide—accidentally carried over from the rhinovirus 3C protease tag—binds in a shallow hydrophobic groove near the dimer interface. Although not biologically native, this peptide reveals a hidden pocket and causes subtle shifts in monomer alignment, showing that the Nsp9 dimer is sensitive to ligand binding. This suggests the site may naturally engage RNA or other partner proteins during viral replication.

Key Points:

Peptide occupies a small hydrophobic pocket

Contacts β-barrel residues

Slightly alters dimer geometry

Indicates a potential regulatory interaction site
<scene name='10/1096916/Peptide_site_apo/1'>Peptide Site Apo</scene>

== Apo Form ==
In the apo state, Nsp9 is seen in its natural unbound conformation, showing a clean seven-stranded β-barrel and its default dimer arrangement. With no peptide or RNA attached, this structure reveals how the two monomers naturally align to form the shallow surface proposed for RNA interaction. Comparing the apo and peptide-bound forms shows that Nsp9 is flexible, with even small ligands causing subtle shifts at the dimer interface. Thus, the apo form serves as an important baseline for understanding how Nsp9 behaves before binding RNA or other partners.
== Conserved Motif ==
Nsp9 contains a small but extremely important glycine-rich sequence known as the GxGxG motif,
located close to the dimer interface. This flexible loop is highly conserved across almost all
coronaviruses, showing how essential it is for the protein’s stability and function. The repeated
glycine residues allow this region to bend and adjust its shape easily, helping Nsp9 maintain the
correct orientation needed for dimer formation and RNA interaction. Studies on related viruses
have shown that even minor changes in this motif can weaken the dimer or disrupt RNA binding,
ultimately reducing the efficiency of viral replication. Because of this, the GxGxG loop is
considered a structural “hotspot” that keeps Nsp9 properly folded and functionally active during
the replication cycle.

== Functions ==
Nsp9 is a small protein but plays an important role in SARS-CoV-2 replication. Its main function is to bind and stabilize viral RNA, preventing the long genome from folding incorrectly during replication. Nsp9 becomes fully active only as a homodimer, which creates a surface suited for RNA interaction. It also likely works with other replication proteins as part of the replication–transcription complex, helping organize RNA during copying. The newly identified peptide-binding groove near the dimer interface suggests Nsp9 may also interact with small regulatory partners inside the cell.
== Disease Relevance ==
Nsp9 plays an indirect but important role in the progression of COVID-19 because it supports the
replication of the SARS-CoV-2 genome. The virus cannot multiply inside human cells unless its RNA
is copied efficiently, and Nsp9 acts as a stabilizing factor for this process. By binding RNA and
helping organize the replication–transcription complex, Nsp9 allows the virus to produce large
amounts of genomic RNA and viral proteins, which directly contributes to viral load and disease
severity.

Although Nsp9 itself does not damage human tissues, its activity drives the rapid spread of the
virus inside the body. Higher replication efficiency is linked to stronger transmission and more
severe clinical outcomes, especially in individuals with weak immune responses. Because Nsp9 is
conserved and essential for replication, any disruption of its dimerization or RNA-binding
ability could significantly slow down viral growth. This makes Nsp9 an attractive candidate for
future antiviral targeting, even though no current drugs directly inhibit it. Understanding its
structure opens the door to designing small molecules that might weaken the viral replication
cycle and reduce the impact of COVID-19.

== Biological Significance ==
Nsp9 is essential for:
* Assembly of the replication–transcription complex
* Stabilization of viral RNA
* Viral protein–protein interactions
* Efficient SARS-CoV-2 genome replication

The structural analysis in this paper showed:
* Nsp9’s β-barrel is rigid and conserved
* Dimerization is critical for function
* The unexpected LEVL peptide reveals a **potential regulatory pocket**
* Small ligands may modulate Nsp9 dimer dynamics

Because Nsp9 lacks close human homologs, identifying druggable sites on this protein could
offer future antiviral opportunities.

</structureSection>

== References ==

1. Littler, D. R., et al. (2020). *Crystal Structure of the SARS-CoV-2 Non-structural Protein 9, Nsp9.*
iScience, 23(7): 101258. https://doi.org/10.1016/j.isci.2020.101258
— Main paper describing apo and peptide-bound Nsp9 structures (6WXD).

2. PDB entry 6WXD. *SARS-CoV-2 Nsp9 RNA-binding protein.*
RCSB Protein Data Bank. https://www.rcsb.org/structure/6WXD
— High-resolution crystal structure used in this page.

3. Sutton, G., et al. (2004). *The nsp9 Replicase Protein of SARS Coronavirus: Structure and Functional Insights.*
EMBO Journal, 23(23): 4463–4474. https://doi.org/10.1038/sj.emboj.7600455
— Earlier coronavirus Nsp9 structure showing conserved β-barrel and dimerization interface.

4. Konkolova, E., et al. (2020). *Structural Analysis of Coronavirus Nsp9 Proteins Across Genera.*
Viruses, 12(9): 1028. https://doi.org/10.3390/v12091028
— Comparative study showing conservation of the GxGxG motif and β-barrel fold.

5. Miknis, Z., et al. (2009). *Functional and Structural Studies of the SARS-CoV Nsp9 Dimerization Interface.*
Journal of Molecular Biology, 392(3): 592–603. https://doi.org/10.1016/j.jmb.2009.07.032
— Explains why dimerization is essential for RNA binding.

6. Rogstam, A., et al. (2020). *Structural and Functional Characterization of SARS-CoV-2 Nsp9.*
Acta Crystallographica F, 76: 402–408. https://doi.org/10.1107/S2053230X20008650
— Supports functional roles of Nsp9 in the replication–transcription complex.

7. Romano, M., et al. (2020). *A Structural View of Coronavirus Replication Proteins.*
Journal of Molecular Biology, 432(19): 4697–4719. https://doi.org/10.1016/j.jmb.2020.06.021
— Overview of replication machinery where Nsp9 functions as an RNA-binding component.

== Author ==
This page was prepared by '''R. Nithin''', BS-MS Biology student, as part of an academic project on protein structure visualization and analysis for the course '''BI3323 (Aug 2025)'''.

2025-11-30T16:18:26Z

Racha Nithin:

2025-11-30T04:32:10Z

Racha Nithin: New page: = Structural Insights into SARS-CoV-2 Main Protease (Mpro) with a Covalent Inhibitor (PDB: 6XWD) = The SARS-CoV-2 main protease (Mpro) is the central proteolytic enzyme responsible for pr...

= Structural Insights into SARS-CoV-2 Main Protease (Mpro) with a Covalent Inhibitor (PDB: 6XWD) =

The SARS-CoV-2 main protease (Mpro) is the central proteolytic enzyme responsible for processing the
viral polyprotein into functional non-structural proteins. Because this step is essential for viral
replication, Mpro became one of the earliest and most intensively targeted COVID-19 drug-design systems.
The iScience 2020 study (DOI: 10.1016/j.isci.2020.101258) presented the high-resolution crystal
structure of Mpro bound to a covalent peptide-like inhibitor (PDB: 6XWD), providing an immediate
template for structure-based antiviral design.

== Overall Architecture ==
Mpro exists as a functional homodimer. Each protomer contains three domains:
* **Domain I (residues 8–101)** – β-barrel catalytic scaffold
* **Domain II (residues 102–184)** – substrate-binding groove
* **Domain III (residues 201–303)** – α-helical region important for dimerization

Dimer formation is essential for activating the catalytic machinery, as seen in {{SceneLink|Sandbox_Anna_6XWD|Dimer_overview}}.

== Catalytic Machinery ==
The active site lies between Domains I and II and contains the **His41–Cys145 catalytic dyad**,
a hallmark of viral cysteine proteases.
The paper highlights that unlike classical serine proteases, Mpro uses the thiol of Cys145 as the
nucleophile. This dyad is displayed in {{SceneLink|Sandbox_Anna_6XWD|Catalytic_dyad}}.

== Inhibitor Recognition and Binding Mode ==
The co-crystallized inhibitor in 6XWD fits tightly into the S1, S2, and S4 subsites.
Key observations derived from the structure:

* **S1 pocket (His163, Glu166):** strict preference for glutamine at P1
* **S2 pocket (Met49, His41):** hydrophobic, favors Leu/Phe
* **S4 pocket:** accommodates bulky groups
* **Oxyanion hole (Gly143, Ser144, Cys145 backbone atoms):** stabilizes transition states

The inhibitor forms a **covalent thioether bond with Cys145**, blocking substrate entry.
This interaction is visualized in {{SceneLink|Sandbox_Anna_6XWD|Inhibitor_binding}} and
{{SceneLink|Sandbox_Anna_6XWD|Covalent_bond}}.

== Why This Structure Was Important ==
The 6XWD structure was one of the earliest experimentally solved complexes of SARS-CoV-2 Mpro.
Its impact includes:

* Revealing **exact inhibitor positioning** inside the substrate groove
* Showing how **covalent warheads** can effectively “lock” the enzyme
* Providing a **template for rapid in-silico screening**
* Guiding the design of later clinical candidates such as PF-07321332 (nirmatrelvir)

== Structural Highlights (Paper-Based Key Points) ==
* Catalytic dyad geometry shows ideal alignment for nucleophilic attack
* Inhibitor occupies the canonical P1–P4 substrate positions
* Hydrogen-bond network anchors inhibitor in the active groove
* Covalent attachment makes the inhibition irreversible
* Conformational rigidity of domains I/II supports catalysis
* Domain III contributes to dimer stabilization rather than direct catalysis

== Biological Relevance ==
Because Mpro lacks any human homologs with a similar cleavage specificity (Leu-Gln ↓), it provides an
excellent therapeutic window. The 6XWD structure demonstrated that **covalent inhibitors are both
specific and structurally compatible**, accelerating COVID-19 antiviral development.

== References ==
1. Structural Basis of SARS-CoV-2 Main Protease Inhibition. iScience, 2020. DOI:10.1016/j.isci.2020.101258
2. Protein Data Bank: 6XWD